Patients who have one or more boxes of Daflon at home with the lot number 6068122 are asked to “return them to their pharmacy for replacement.”
:quality(50)/2023/07/06/64a68815cd1a7_placeholder-36b69ec8.png)
Published
Reading time: 1 min
:quality(50)/2024/08/12/067-360677-66ba39c221ed7219234836.jpg)
The French National Agency for the Safety of Medicines (ANSM) announced on Monday, August 12, the recall of a batch of boxes of Daflon, a treatment commonly used to stimulate blood circulation and combat hemorrhoid attacks.traces of trimetazidine, a prescription drug used for angina in the adult”which is not included in the composition of the medicine, “were identified in Daflon lot 6068122”explains the drug regulator on its website.
The ANSM invites patients who have a box of Daflon bearing this batch number at home to “take it back to their pharmacy to have it replaced”Questioned by AFP, the ANSM specified that the batch concerned by the recall consists of 13,000 boxes of Daflon 500 mg, a medicine sold without a prescription.
“To date, no pharmacovigilance cases related to this quality defect have been reported.”assures the agency, adding that “investigations are currently being carried out” to determine its origin. “According to the analyses carried out by the laboratory on this batch, the very small quantities of trimetazidine detected do not present a risk for patients who may have been exposed to it.”states the ANSM.
